Anlotinib plus penpulimab has demonstrated encouraging activity and safety in a phase 2 study. In this phase 3 trial, we aimed to assess whether the combination of anlotinib plus penpulimab improved ...

The positive view on YUM is that it pairs global scale and capital-light, franchise-led growth with a technology platform that improves store operations and could provide alternative profit ...

In people with overweight or obesity, amycretin appeared safe and tolerable. Results from this first-in-human, phase 1 study support further investigation of the weight loss properties of amycretin.

Bloveslife makes the case for Jollibee as the ultimate family mukbang go-to.

Jollibee Group Q1 2025 Financial Highlights show strong sales and revenue growth, with systemwide sales up 18.9% and revenue up 14.6% year-on-year.

Asrar A. Alahmadi, MBBS, is heading a first-in-human, open-label, phase 1 clinical trial (NCT06801002) investigating JBZ-001, an orally bioavailable small-molecule inhibitor of dihydroorotate ...

Kate Middleton made her first public appearance since missing Royal Ascot, planting a rose named in her honor at a hospital garden, where she opened up about her cancer journey.

Shares of Yum! Brands Inc. YUM rallied 1.48% to $150.37 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0. ...

Voting to determine the starting lineups for the American League and National League teams at the 2025 MLB All-Star Game has reached its final round. Here's everything to know about the process.